These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 8863991
1. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography. Sudo K, Inoue H, Shimizu Y, Yamaji K, Konno K, Shigeta S, Kaneko T, Yokota T, Shimotohno K. Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991 [Abstract] [Full Text] [Related]
2. The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase. Attwood MR, Bennett JM, Campbell AD, Canning GG, Carr MG, Conway E, Dunsdon RM, Greening JR, Jones PS, Kay PB, Handa BK, Hurst DN, Jennings NS, Jordan S, Keech E, O'Brien MA, Overton HA, King-Underwood J, Raynham TM, Stenson KP, Wilkinson CS, Wilkinson TC, Wilson FX. Antivir Chem Chemother; 1999 Sep; 10(5):259-73. PubMed ID: 10574181 [Abstract] [Full Text] [Related]
3. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. Butkiewicz N, Yao N, Zhong W, Wright-Minogue J, Ingravallo P, Zhang R, Durkin J, Standring DN, Baroudy BM, Sangar DV, Lemon SM, Lau JY, Hong Z. J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044 [Abstract] [Full Text] [Related]
4. A novel high throughput screening assay for HCV NS3 serine protease inhibitors. Berdichevsky Y, Zemel R, Bachmatov L, Abramovich A, Koren R, Sathiyamoorthy P, Golan-Goldhirsh A, Tur-Kaspa R, Benhar I. J Virol Methods; 2003 Feb; 107(2):245-55. PubMed ID: 12505640 [Abstract] [Full Text] [Related]
5. NS3-4A of hepatitis C virus is a chymotrypsin-like protease. Hahm B, Han DS, Back SH, Song OK, Cho MJ, Kim CJ, Shimotohno K, Jang SK. J Virol; 1995 Apr; 69(4):2534-9. PubMed ID: 7884903 [Abstract] [Full Text] [Related]
6. Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease. Du GX, Hou LH, Guan RB, Tong YG, Wang HT. World J Gastroenterol; 2002 Dec; 8(6):1088-93. PubMed ID: 12439931 [Abstract] [Full Text] [Related]
7. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Lin C, Rice CM. Proc Natl Acad Sci U S A; 1995 Aug 15; 92(17):7622-6. PubMed ID: 7644466 [Abstract] [Full Text] [Related]
8. Product inhibition of the hepatitis C virus NS3 protease. Steinkühler C, Biasiol G, Brunetti M, Urbani A, Koch U, Cortese R, Pessi A, De Francesco R. Biochemistry; 1998 Jun 23; 37(25):8899-905. PubMed ID: 9636031 [Abstract] [Full Text] [Related]
9. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. Lin C, Prágai BM, Grakoui A, Xu J, Rice CM. J Virol; 1994 Dec 23; 68(12):8147-57. PubMed ID: 7966606 [Abstract] [Full Text] [Related]
10. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Sali DL, Ingram R, Wendel M, Gupta D, McNemar C, Tsarbopoulos A, Chen JW, Hong Z, Chase R, Risano C, Zhang R, Yao N, Kwong AD, Ramanathan L, Le HV, Weber PC. Biochemistry; 1998 Mar 10; 37(10):3392-401. PubMed ID: 9521660 [Abstract] [Full Text] [Related]
11. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors. Lee JC, Yu MC, Lien TW, Chang CF, Hsu JT. Assay Drug Dev Technol; 2005 Aug 10; 3(4):385-92. PubMed ID: 16180993 [Abstract] [Full Text] [Related]
12. An in vitro assay for hepatitis C virus NS3 serine proteinase. Bouffard P, Bartenschlager R, Ahlborn-Laake L, Mous J, Roberts N, Jacobsen H. Virology; 1995 May 10; 209(1):52-9. PubMed ID: 7747484 [Abstract] [Full Text] [Related]
13. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells. Lee JC, Chang CF, Chi YH, Hwang DR, Hsu JT. J Virol Methods; 2004 Mar 01; 116(1):27-33. PubMed ID: 14715304 [Abstract] [Full Text] [Related]
14. Establishment and application of high throughput screening model for hepatitis C virus NS3-4A protease inhibitors in vitro. Jian-rui L, Yan-bin W, Shu-yi S, Hong-shan C, Jian-dong J, Zong-gen B. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb 01; 33(1):98-101. PubMed ID: 21375947 [Abstract] [Full Text] [Related]
15. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. Urvil PT, Kakiuchi N, Zhou DM, Shimotohno K, Kumar PK, Nishikawa S. Eur J Biochem; 1997 Aug 15; 248(1):130-8. PubMed ID: 9310370 [Abstract] [Full Text] [Related]
16. Kinetic and structural analyses of hepatitis C virus polyprotein processing. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H. J Virol; 1994 Aug 15; 68(8):5045-55. PubMed ID: 8035505 [Abstract] [Full Text] [Related]
17. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity. Hahm B, Back SH, Lee TG, Wimmer E, Jang SK. Virology; 1996 Dec 15; 226(2):318-26. PubMed ID: 8955051 [Abstract] [Full Text] [Related]
18. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity. Butkiewicz NJ, Wendel M, Zhang R, Jubin R, Pichardo J, Smith EB, Hart AM, Ingram R, Durkin J, Mui PW, Murray MG, Ramanathan L, Dasmahapatra B. Virology; 1996 Nov 15; 225(2):328-38. PubMed ID: 8918919 [Abstract] [Full Text] [Related]
19. Establishment of an in vitro assay to characterize hepatitis C virus NS3-4A protease trans-processing activity. Hamatake R, Wang HG, Butcher JA, Bifano M, Clark G, Hernandez D, Zhang S, Racela J, Standring D, Colonno R. Intervirology; 1996 Nov 15; 39(4):249-58. PubMed ID: 9078466 [Abstract] [Full Text] [Related]
20. Identification of amino acid variants in the hepatitis C virus non-structural protein 4A. Bermúdez-Aguirre AD, Padilla-Noriega L, Zenteno E, Reyes-Leyva J. Tohoku J Exp Med; 2009 Jul 15; 218(3):165-75. PubMed ID: 19561386 [Abstract] [Full Text] [Related] Page: [Next] [New Search]